Jason C. Jones - 16 Nov 2022 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Senior VP Product Development
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Issuer symbol
EKSO
Transactions as of
16 Nov 2022
Transactions value $
-$1,003
Form type
4
Filing time
17 Nov 2022, 16:49:12 UTC
Previous filing
02 Sep 2022
Next filing
06 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Sale -$1K -782 -0.62% $1.28 125K 16 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person on November 16, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the third installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on April 2, 2020
F2 These shares were sold in a single transaction at a price of $1.2825 per share.